The effectiveness of a monopreparation containing a combination of ciprofloxacin – ornidazole in the treatment of infectious-inflammatory and dysbiotic vagina diseases

The effectiveness of a monopreparation containing a combination of ciprofloxacin – ornidazole in the treatment of infectious-inflammatory and dysbiotic vagina diseases

Introduction. Infectious inflammatory and dysbiotic diseases of the vagina represent a major concern facing obstetric and gynecological science. Individually, the two most common specific diseases can be distinguished, namely: bacterial vaginosis (BV) and nonspecific vaginitis (NV). The therapeutic...

Full description

Bibliographic Details
Main Authors:	V. F. Bezhenar, O. L. Molchanov, I. V. Kukes, A. A. Meznikov, L. A. Galiullina, A. Yu. Zosimovskiy, A. L. Poznyak
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2021-10-01
Series:	Медицинский совет
Subjects:	bacterial vaginosis nonspecific vaginitis ciprofloxacin ornidazole orcepol wm
Online Access:	https://www.med-sovet.pro/jour/article/view/6420

Similar Items

Three new, UV spectrum filtration protocols for the synchronous quantification of ciprofloxacin HCl and ornidazole in the existence of ciprofloxacin-induced degradation compound
by: Amir Alhaj Sakur, et al.
Published: (2023-12-01)

Evaluation of Ornidazole Gel as an Adjunct to the Phase I Therapy
by: Bhavin Patel, et al.
Published: (2014-01-01)

Fixed drug eruption due to ornidazole
by: Ramji Gupta
Published: (2014-01-01)

Use of ornidazole in the treatment of anaerobic infection in surgery
by: Yu M Babina, et al.
Published: (2021-03-01)

Efficacy of ornidazole for pericoronitis: a meta-analysis and systematic review
by: Ruobing Du, et al.
Published: (2024-01-01)

Development of new dissolution test and HPLC-RP method for anti-parasitic ornidazole coated tablets
by: Mônica Felts de La Roca Soares, et al.
Published: (2010-01-01)

Toxicological parameters of the drug based on Ornidazole and Levamisole hydrochloride
by: A. V. Butenko, et al.
Published: (2023-01-01)

Secnidazole for treatment of bacterial vaginosis: a systematic review
by: Mohamed A. Abd El Aziz, et al.
Published: (2019-10-01)

Ofloxacin-ornidazole fixed-dose combination medication-induced pancreatitis with positive rechallenge
by: Nikhil Bush, et al.
Published: (2020-01-01)

Ornidazole Transfer into Colostrum and Assessment of Exposure Risk for Breastfeeding Infant: A Population Pharmacokinetic Analysis
by: Sichan Li, et al.
Published: (2023-10-01)

Prevention of dysbiotic and inflammatory diseases of the vagina and vulva after surgical correction of genital prolapse and stress urinary incontinence
by: Irina A. Lapina, et al.
Published: (2020-12-01)

Ornidazole-Induced Recurrent Encephalopathy in a Chinese Man: A Rare Case Report and Literature Review
by: Rong Tang, et al.
Published: (2021-09-01)

A combined electrochemical and DFT investigation of ornidazole as a benign anti-corrosion agent for carbon steel materials in acidizing environments
by: Alexander I. Ikeuba, et al.
Published: (2024-03-01)

An impact of the combined drug containing antimicrobial, antiprotozoal, antifungal and glucocorticoid agents on local immunity in women with bacterial vaginosis and non-specific vaginitis
by: O. M. Bokach, et al.
Published: (2021-06-01)

Construction of an ornidazole/bFGF-loaded electrospun composite membrane with a core-shell structure for guided tissue regeneration
by: Wen Zhang, et al.
Published: (2022-09-01)

Comparing the effect of combination of 1% ornidazole and 0.25% chlorhexidine gluconate (Ornigreat™) gel and Aloe Vera gel in the treatment of chronic periodontitis: A randomized, single-blind, split-mouth study
by: Gautami Subhadra Penmetsa, et al.
Published: (2019-01-01)

Characterization of ornidazole metabolites in human bile after intraveneous doses by ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry
by: Jiangbo Du, et al.
Published: (2012-04-01)

Chronic cervicitis in women of reproductive age: pathogenesis and treatment. A review
by: Vera N. Prilepskaya, et al.
Published: (2023-12-01)

VAGINAL BIOCENOSIS IN PREGNANT WOMEN
by: A. V. Podgornaya, et al.
Published: (2017-12-01)

Vaginitis caused by conditionally pathogenic microflora: international and home protocols analysis
by: O A Pustotina
Published: (2014-10-01)

A Comparative Evaluation of the Effectiveness of Three Different Irrigating Solution on Microorganisms in the Root Canal: An Invivo Study
by: Priya Jain, et al.
Published: (2015-12-01)

The effectiveness of complex therapy in the treatment of nonspecific vaginitis in women of reproductive age
by: O.D. Ryazanova, et al.
Published: (2022-12-01)

Effects of magnesium deficiency on stress manifestations in women of reproductive age with nonspecific vaginitis
by: O. D. Riazanova, et al.
Published: (2022-11-01)

OPTIMIZATION OF ANTIBACTERIAL THERAPY FOR NONSPECIFIC VAGINITIS IN WOMEN OF REPRODUCTIVE AGE
by: O. D. Ryazanova, et al.
Published: (2022-09-01)

Vulvovaginitis and vaginosis treatment: clinical and laboratory efficiency
by: V N Prilepskaya, et al.
Published: (2013-08-01)

Pharmacokinetics of ciprofloxacin in layer chicks
by: B. S. AI – Khafaji, et al.
Published: (1999-06-01)

SPLINTER HEMORRHAGE AS A SIDE EFFECT OF CIPROFLOXACIN
by: Ilkay Bozkurt
Published: (2013-10-01)

Nitroimidazole Derivative Antimicrobial Drugs and Liver Injury
by: Uğur Balaban, et al.
Published: (2023-09-01)

Classical versus chemometrics tools for spectrophotometric determination of fluocinolone acetonide, ciprofloxacin HCl and ciprofloxacin impurity-A in their ternary mixture
by: Mahmoud A. Tantawy, et al.
Published: (2023-06-01)

Modern ideas about the etiology, pathogenesis, diagnosis and treatment of chronic nonspecific cervicitis
by: A. A. Odyvanova, et al.
Published: (2022-08-01)

Ciprofloxacin but not amoxicillin significantly elevated serum peroxynitrite level in patients with enteric (typhoid fever): In vitro study
by: Marwan S.M. Al-Nimer, et al.
Published: (2006-10-01)

Ciprofloxacin Induced Antibiomania
by: Ramdas Sarjerao Ransing, et al.
Published: (2016-12-01)

Pathophysiological changes at single and multiple introduction of Ciprofloxacin solution under experimental conditions
by: A. G. Yushkov, et al.
Published: (2013-09-01)

Different Nanotechnology Approaches for Ciprofloxacin Delivery Against Multidrug-Resistant Microbes
by: Yayehrad AT, et al.
Published: (2022-02-01)

Single vs Multiple Antibiotic Drug Regimen in Preventing Infectious Morbidity in Caesarean Section: A Randomised Clinical Trial
by: Subhashchandra R Mudanur, et al.
Published: (2021-07-01)

Ruggedness testing of an HPLC method for the determination of ciprofloxacin
by: Sibinović Predrag, et al.
Published: (2005-01-01)

Ruggedness testing of an HPLC method for the determination of ciprofloxacin
by: PREDRAG SIBINOVIC, et al.
Published: (2005-07-01)

Vaginal Dysbiotic Microbiome in Women With No Symptoms of Genital Infections
by: Rinku Pramanick, et al.
Published: (2022-01-01)

Cholestatic hepatitis with ciprofloxacin therapy: A Case Report
by: A. R. M. Misthaq, et al.
Published: (2019-10-01)

CLINICAL FEATURES AND MANAGEMENT OF PATIENTS WITH DYSPLASIA OF CERVICAL EPITHELIUM ON THE BACKGROUND OF ABNORMAL MICROBIOCENOSIS OF VAGINA
by: V. V. Schaefer, et al.
Published: (2018-05-01)